Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.3, 1999-03, pp. : 155-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David Lyseng-Williamson Katherine A.

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack Lesley J. Scott

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite

The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS

By O'Connor P.

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2865-2874

Elsevier

Access to resources Recommend Favorite

Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

By Wagstaff A.J. Goa K.L.

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 471-494

Adis International

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in Multiple Sclerosis

By Achiron A.

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 465-475

Adis International

Access to resources Recommend Favorite